Navigation Links
Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
Date:5/8/2012

BETHESDA, Md., May 8, 2012 /PRNewswire-iReach/ -- Reimbursement strategy has become an integral component of drug and device development and commercialization plan. For new product launches it is becoming critical to demonstrate clinical, safety, economic and quality of life benefits versus comparators to payers, providers and patients. Novel Health Strategies, LLC's presentations at ISPOR 2012 highlight these trends: 

IMPACT OF 2009-2011 GLOBAL HEALTH CARE REFORMS ON PRICING, ACCESS AND HEALTH OUTCOMES STRATEGY (UT2, Tuesday, June 5, 2012, Podium Presentation)

COST EFFECTIVENESS TRENDS OF HIGH BUDGET IMPACT DRUGS (2006-2012) (CE1, Monday, June 4, 2012, Podium Presentation)

DEVELOPING BUDGET IMPACT MODEL FOR RARE DISEASES: CASE IN POINT CUTANEOUS T-CELL LYMPHOMA (PCN30, Wednesday, June 6, 2012)

ELECTRONIC PATIENT REPORTED OUTCOMES AND DATA TOOL FOR CHRONIC DISEASE MANAGEMENT (PROCDIM): CASE IN POINT PROSTATE CANCER (PIH32, Tuesday, June 5, 2012)

ONCOLOGY DRUG PRICES IN THE UNITED STATES AND THE UNITED KINGDOM: IMPLICATIONS FOR PRICING STRATEGY AND DRUG ACCESS (PCN116, Wednesday, June 6, 2012)

SYSTEMATIC REVIEW OF CLINICAL EFFICACY AND SAFETY OUTCOMES OF ANTI-VEGF THERAPIES FOR METASTATIC COLORECTAL CANCER (PCN114, Wednesday, June 6, 2012)

SYSTEMATIC REVIEW OF INTERFERON FREE BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT (PIN5, Wednesday, June 6, 2012)

TRENDS IN RATE AND COST OF HOSPITALIZATIONS DUE TO CHRONIC KIDNEY DISEASE (CKD) IN THE UNITED STATES (PUK13, Tuesday, June 5, 2012)

Relevant References:

*Targeted Cancer Therapies, Nature Reviews Drug Discovery 9, 427-428 (June 2010)
http://novelhealthstrategies.com/Targeted_Cancer_Therapies.pdf
*What's Fueling the Biotech Engine-2010 to 2011, Nature Biotechnology 29, 1083–1089 (2011)
http://www.nature.com/nbt/journal/v29/n12/abs/nbt.2060.html
*Impact of 2009-2011 Global Healthcare Reforms on Access, Pricing and Health Outcomes Strategy, June 2, 2012
http://www.ispor.org/meetings/washingtondc0512/Program_060512.asp#podiums3

About Novel Health Strategies
Novel Health Strategies, LLC (http://www.novelhealthstrategies.com) is an award winning team of experienced professionals with expertise in healthcare strategy, research, policy, publications, health economics and outcomes research, modeling, and pricing and market access strategy. Novel Health team has led strategy projects for majority of top 50 pharmaceutical, biotech and device companies. Novel Health has large network of internal and external stakeholders and has published several thought leading strategy perspectives, including the 'What's fueling the biotech engine' annual series in Nature Biotech, cited and quoted by more than two hundred peer-reviewed publications and agencies (FDA, EMA and others). Novel Health has presented industry trends and perspectives at ISPOR, AMCP and BIO meetings. To learn more about Novel Health team's experience, case studies and capabilities, contact at the address on this press release.

Media Contact: Saurabh Aggarwal, PhD Novel Health Strategies, LLC, (202) 618-9365, info@novelhealthstrategies.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Novel Health Strategies, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
3. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
4. IDM Pharma Announces Upcoming Clinical Data Presentations
5. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
8. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
9. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
10. Genmab Announces Upcoming Ofatumumab Studies
11. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, ... tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , PhD, ...
(Date:9/13/2017)... 13, 2017   OrthoAtlanta has been named the ... Host Committee (AFHC) for the 2018 College Football Playoff (CFP) ... at Mercedes-Benz Stadium in Atlanta, Georgia . ... "I,m In" campaign, participating in many activities leading up to, ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
Breaking Medicine News(10 mins):